Tag: lung carcinoma

Latest FDA Pembrolizumab Approval Expands Label to Cutaneous SCCs

The Food and Drug Administration has approved pembrolizumab (Keytruda) monotherapy for locally advanced cutaneous squamous cell carcinoma (cSCC) that can’t be cured by surgery or...

Oncologist Accused of Inappropriate Treatment ‘Provided Exceptional Care’

MANCHESTER—Leading oncologist Professor Justin Stebbing has told a medical tribunal he provided “exceptional standards of care” to a cancer patient he’s accused of giving chemotherapy...

Health Policy Expert Peter Bach, MD, Goes to Biotech Company

A well-known healthcare policy expert whose work has focused on the cost and value of anticancer drugs has left academia and has accepted a position...

Immunotherapy Combo Now Approved for First-Line Mesothelioma in EU

Combination therapy with the immunotherapies nivolumab (Opdivo) and ipilimumab (Yervoy) is now approved in the European Union for the first-line treatment of adults with unresectable...

First Drug for Lung Cancer With KRAS Mutation Gains FDA Approval

The first drug to target KRAS mutations in non-small cell lung cancer (NSCLC) has been approved by the US Food and Drug Administration. KRAS mutations...

FDA OKs First Targeted Therapy for Subset of Patients With NSCLC

The US Food and Drug Administration (FDA) today granted an accelerated approval for amivantamab (Rybrevant) as the first targeted treatment for patients with non–small cell...

Loneliness in Middle-Aged Men Linked to Increased Cancer Risk

Loneliness among middle-aged men ups their risk of cancer, and being single at the time of diagnosis confers a worse prognosis, suggest results from a...

Dramatic Rise in Use of Drugs for Opioid-Induced Constipation

A call for more appropriate use of a new class of drugs for the treatment of opioid-induced constipation (OIC) has been issued by researchers who...

FDA Approves Cemiplimab-rwlc for NSCLC With PD-L1 Expression

The US Food and Drug Administration (FDA) has approved cemiplimab-rwlc (Libtayo) for the treatment of advanced non–small cell lung cancer (NSCLC). Specifically, the indication is...

Rush Limbaugh Dies at 70 Following Lung Cancer Diagnosis

Feb. 17, 2021 — Rush Limbaugh, for decades a popular, controversial, and influential talk radio host and conservative commentator, died Wednesday, according to a family...

Amivantamab Shows Promise in Challenging EGFR-Mutated NSCLC

A novel drug, the immune cell-directing antibody amivantamab (under development by Janssen), has shown promise for the treatment of patients with non–small cell lung cancer...

Tofacitinib for RA Misses the Mark in Safety Study

Daily treatment with tofacitinib (Xeljanz) led to more malignancies and adverse cardiovascular events in older rheumatoid arthritis patients compared with treatment with a tumor necrosis...

Baby Gets Cancer From Mother During Birth: First Report

Cancer can be transmitted from a mother with cervical cancer to a newborn when the baby passes through the birth canal. That’s the conclusion of...

Invasive Tests Prompted by Cancer Screening Show High Real-World Complication Rate

NEW YORK (Reuters Health) – In real-world circumstances, procedures such as biopsy indicated by lung-cancer screening with low-dose computed tomography (LDCT) may not go quite...

Most Common Cancer Diagnosis Globally: Breast Surpasses Lung

Breast cancer now tops the list of the most commonly diagnosed cancers worldwide, surpassing lung cancer for the first time, according to the latest global...

Lung Cancer CT Is Chance for ‘Opportunistic’ Osteoporosis Check

Low-dose chest CT for lung cancer screening provides the opportunity to simultaneously screen patients for osteoporosis, detecting notably higher rates of osteoporosis in men than...

Real-World Results With Checkpoint Inhibitors Inferior to CT Data

Real-world survival outcomes for cancer patients on immune checkpoint inhibitors (ICIs) are inferior to outcomes reported in patients on clinical trials of ICIs, according to research...

UK Physicians Call for Fresh Debate on Medically Assisted Dying

Medically assisted dying is illegal in the United Kingdom, but it continues to be debated. Now three physicians argue that it’s time for a fresh...

FDA OKs Combo Therapy for First-Line Mesothelioma Treatment

The US Food and Drug Administration (FDA) has approved combination nivolumab (Opdivo, Bristol-Myers Squibb) and ipilimumab (Yervoy, Bristol-Myers Squibb) to be used as first-line treatment...

Global Stomach Cancer Deaths Decline as CRC Deaths Stagnate, Rise

A global analysis of premature deaths from noncommunicable diseases (NCDs) has shown mixed results for gastrointestinal (GI) cancers. The data suggest fewer people are dying...

Survey Quantifies COVID-19’s Impact on Oncology

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. An international survey provides new insights into how COVID-19 has affected,...

Selpercatinib ‘Poised to Alter the Landscape’ of RET+ve Cancers

Clinical data for the first-ever RET inhibitor, selpercatinib (Retevmo), show efficacy in two groups of patients with cancer ― those with RET fusion–positive non–small cell...

Performance Status, Molecular Testing Key to Cancer Prognosis

Performance status and molecular testing results are key tools in prognosticating for patients with newly diagnosed metastatic solid tumors, according to Sam Brondfield, MD, MA,...

No Increase in Risk of Death From COVID-19 in Cancer Patients

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Immune checkpoint inhibition was not associated with an increased mortality risk...

In a First, Proton Therapy Bests Radiotherapy in an RCT

In a first, proton beam therapy has demonstrated significantly reduced toxicity when compared with conventional radiotherapy in a randomized controlled trial (RCT) in patients with...